Xeraya Capital

was appointed Chief Executive Officer (CEO) of Xeraya Capital Sdn Bhd in January 2012.

is the current Chief Financial Officer of Xeraya, bringing more than 20 years of audit, transaction, advisory, corporate finance, taxation and risk management experience.

officially joined Xeraya as an Advisor from 1st February 2015. Datuk Abd Hapiz brings with him a wealth of chemical industry experience with strong business networks, especially in the Asia Pacific region.

brings with him a wealth of medical device manufacturing and commercialisation knowledge and venture partnering experience with strong business networks, especially in the Asia Pacific region.

officially joined Xeraya in January 2016. Bruce brings with him a wealth of business leadership experience in the areas of pharmaceuticals, medical technology and digital health, with strong business networks in the United States.

was part of the founding member of Xeraya bringing accumulated domain expertise in technology investment, management consulting, corporate strategy and operations.

was part of the founding team of Xeraya and has more than 20 years of experience and leadership in financing new ventures, corporate investing, and international expansion in the life sciences and technology industries.

brings with him a wealth of life sciences experience and strong business networks, especially in Europe.

is the Senior Vice President of Investments, bringing experience that spans across both private equity and venture capital investments.

joined Xeraya Capital as the Senior Vice President and bringing more than 15 years of experience in the life sciences ecosystem from research, academia, management and policy making.

joined Xeraya in 2016 with more than 10 years of experience working on investments in life sciences, specifically the healthcare sector and economic development initiatives.

joined Xeraya Capital in 2012 with a diverse background ranging across biotechnology, intellectual property and business management.